Mitesh J Borad (Mitesh Borad)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Advanced Cancer

Clinical Practice

Top Venues

JCO precision oncology

Cancer research communications

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Mitesh J Borad
Introducing the PLOS collection on rare cancer. PloS one 19 (7) (2024)
Mitesh J Borad
Introducing the PLOS collection on rare cancer. PloS one 19 (7) (2024)
Mitesh J Borad
Introducing the PLOS collection on rare cancer. PloS one 19 (7) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase 1 Study of KIN-3248, an irreversible small molecule pan-FGFR inhibitor, in Patients with Advanced FGFR 2/3 Driven Solid Tumors. Cancer research communications (2024)
Benjamin E Ueberroth, Richard John Presutti, Alyssa McGary, Mitesh J Borad, Neera Agrwal
Perspectives of primary care providers regarding multicancer early detection panels. Einstein (Sao Paulo, Brazil) 22 (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Benjamin E Ueberroth, Richard John Presutti, Alyssa McGary, Mitesh J Borad, Neera Agrwal
Perspectives of primary care providers regarding multicancer early detection panels. Einstein (Sao Paulo, Brazil) 22 (2024)
Benjamin Garmezy, Mitesh J Borad, Rastislav Bahleda, Cesar A Perez, Li-Tzong Chen, Shumei Kato, Do Youn Oh, Paul Severson, Betty Y Tam, Cheng S Quah, James J Harding
A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors. Cancer research communications 4 (4) (2024)
Leontios Pappas, Islam Baiev, Stephanie Reyes, Andrea Grace Bocobo, Apurva Jain, Kristen Spencer, Tri Minh Le, Osama E Rahma, Jordan Maurer, Jen Stanton, Karen Zhang, Anaemy Danner De Armas, Thomas T Deleon, Marc T Roth, Mary Linton B Peters, Andrew X Zhu, Kylie Boyhen, Christine VanCott, Tushar Patel, Lewis Rowland Roberts, Stacie Lindsey, Nora Horick, Jochen K Lennerz, A John Iafrate, Laura Williams Goff, Kabir Mody, Mitesh J Borad, Rachna T Shroff, Milind M Javle, Robin Kate Kelley, Lipika Goyal
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma. JCO precision oncology 7 (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Louis Y El Khoury, Wan Hsin Lin, James B Smadbeck, Michael T Barrett, Dorsay Sadeghian, Alexa F McCune, Giannoula Karagouga, John C Cheville, Faye R Harris, Lindsey M Kinsella, Ryan W Feathers, Janet L Schafer Klein, Marina Rs Walther-Antonio, Sarah H Johnson, Alan R Penheiter, Giuseppe Cucinella, Gabriella Schivardi, Aditya Bhagwate, Mitesh J Borad, Aaron S Mansfield, Stephen J Murphy, Andrea Mariani, George Vasmatzis, Panos Z Anastasiadis, Saravut J Weroha, Alyssa M Larish
Epigenomics may begin to explain in vitro differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancer. Epigenomics (2023)
Karan K Budhraja, Bradon R McDonald, Michelle D Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F Favaro, Sydney Connor, Sara A Byron, Jan B Egan, Brenda J Ernst, Timothy K McDaniel, Aleksandar Sekulic, Nhan L Tran, Michael D Prados, Mitesh J Borad, Michael E Berens, Barbara A Pockaj, Patricia M LoRusso, Alan H Bryce, Jeffery M Trent, Muhammed Murtaza
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer. Science translational medicine 15 (678) (2023)
Grant A Wintheiser, Tyler Zemla, Qian Shi, Nguyen H Tran, Kritika Prasai, Sri Harsha Tella, Kabir Mody, Daniel Ahn, Mitesh J Borad, Tanios S Bekaii-Saab, Amit Mahipal
Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes. JCO precision oncology 6 (2022)
Savannah S Liddell, Sakti Chakrabarti, Grant A Wintheiser, Tyler J Zemla, Qian Shi, Sri Harsha Tella, Zhaohui Jin, Vanessa B Wookey, Hind Hassan, Nguyen H Tran, Mitesh J Borad, Amit Mahipal
Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer. JCO precision oncology 6 (2022)
Debyani Chakravarty, Amber M Johnson, Jeffrey Sklar, Neal I Lindeman, Kathleen M Moore, Shridar Ganesan, Christine M Lovly, Jane Perlmutter, Stacy W Gray, Jimmy Hwang, Christopher H Lieu, Fabrice Andre, Nilofer S Azad, Mitesh J Borad, Laura Tafe, Hans Messersmith, Mark E Robson, Funda Meric-Bernstam
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (11) (2022)
Jennifer Jane Gile, Aminah Jatoi, Wen Wee Ma, Mitesh J Borad, Nguyen H Tran
Reply to A. Rizzo et al. JCO precision oncology 6 (2022)
Omeed Moaven, Christopher W Mangieri, John A Stauffer, Panos Z Anastasiadis, Mitesh J Borad
Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy. JCO precision oncology 5 (2021)
Alexander T Baker, Ryan J Boyd, Daipayan Sarkar, Alicia Teijeira-Crespo, Chun Kit Chan, Emily Bates, Kasim Waraich, John W Vant, Eric A Wilson, Chloe D Truong, Magdalena Lipka-Lloyd, Petra Fromme, Josh Vincent Vermaas, Dewight R Williams, LeeAnn Machiesky, Meike Heurich, Bolni M Nagalo, Lynda Coughlan, Scott Umlauf, Po-Lin Chiu, Pierre J Rizkallah, Taylor S Cohen, Alan L Parker, Abhishek Singharoy, Mitesh J Borad
ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome. Science advances 7 (49) (2021)
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Yoon-Koo Kang, Shu-Kui Qin, David Wai-Meng Tai, Ho Yeong Lim, Thomas Yau, Wei Peng Yong, Ann-Lii Cheng, Antonio Gasbarrini, Silvia Damian, Jordi Bruix, Mitesh J Borad, Johanna Bendell, Tae-You Kim, Nathan Standifer, Philip He, Mallory Makowsky, Alejandra Negro, Masatoshi Kudo, Ghassan K Abou-Alfa
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (27) (2021)
Jennifer Jane Gile, Fang-Shu Ou, Amit Mahipal, Joseph J Larson, Kabir Mody, Zhaohui Jin, Joleen M Hubbard, Thorvardur R Halfdanarson, Steven R Alberts, Aminah Jatoi, Robert R McWilliams, Wen Wee Ma, Sumera Ilyas, Rory Smoot, Lewis Rowland Roberts, Gregory Gores, Mitesh J Borad, Tanios S Bekaii-Saab, Nguyen H Tran
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience. JCO precision oncology 5 (2021)
Pedro Luiz Serrano Uson Junior, Thomas T DeLeon, James M Bogenberger, Rish K Pai, Heidi E Kosiorek, Jun Yin, Daniel H Ahn, Mohammad Bassam Sonbol, Tanios Bekaii-Saab, Aaron S Mansfield, Kenneth Buetow, Gregory J Gores, Rory Smoot, George Vasmatzis, Benjamin R Kipp, Amit Mahipal, Alexander T Baker, Hani Babiker, Oumar Barro, Chelsae Dumbauld, Yumei Zhou, Faaiq N Aslam, Michael Barrett, Bertram Jacobs, Nathalie Meurice, Mansi Arora, Joachim Petit, Natalie Elliott, Bolni Nagalo, Marcela A Salomao, Mitesh J Borad
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations. Digestive diseases and sciences (2021)
Omeed Moaven, Christopher W Mangieri, John A Stauffer, Panos Z Anastasiadis, Mitesh J Borad
Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice. JCO precision oncology 5 (2021)
Mansi Arora, James M Bogenberger, Amro Abdelrahman, Jennifer L Leiting, Xianfeng Chen, Jan B Egan, Aradhana Kasimsetty, Elzbieta Lenkiewicz, Smriti Malasi, Pedro Luiz Serrano Uson, Bolni Marius Nagalo, Yumei Zhou, Marcela A Salomao, Heidi E Kosiorek, Esteban Braggio, Michael T Barrett, Mark J Truty, Mitesh J Borad
Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer. Cancer chemotherapy and pharmacology 85 (6) (2020)